Search

everythinglearnresearchcommunity

for

Search:↓

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

RXRα is crucial for proper immune response and links diet to immune function.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Some drugs may help treat both COVID-19 and radiation injury.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

The skin's immune system helps it regenerate and fight infections.

Heat treatment increases hair loss in certain mice.